Comparison of Pericapsular Nerve Group Block and Quadratus Lumborum Block
1 other identifier
interventional
80
1 country
1
Brief Summary
Adequate pain management following total hip arthroplasty (THA) is a key component for patient satisfaction and early ambulation. However, due to the complexity of the innervation of the hip joint, the most appropriate anaesthetic and analgesic technique for THA remains unclear. A femoral nerve block is commonly performed and well established but is associated with motor weakness. Recently, the pericapsular nerve group (PENG) block has been introduced as an effective choice which targets the articular branches of the hip. The quadratus lumborum block (QLB) is a relatively new regional block that has been reported to provide effective analgesia for THA. The main objective of this study is to compare the effectiveness of the ultrasound-guided PENG block technique compared to QLB block in terms of efficacy of pain control and the safety profile after total hip arthroplasty under spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 30, 2022
CompletedFirst Posted
Study publicly available on registry
December 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2023
CompletedDecember 20, 2024
April 1, 2023
1.3 years
November 30, 2022
December 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain scores
Numerical Rating Scale-NRS (0 = no pain and 10 = worst imaginable painranged from 0 to 10)
Changes from baseline opioid consumption at postoperative 0, 2, 6, 12 and 24 hours
Opioid consumption
Mean opioid consumption in morphine equivalents
Changes from baseline opioid consumption at postoperative 0, 2, 6, 12 and 24 hours
Secondary Outcomes (3)
Quadriceps muscle strength
Postoperative 24 hours period
Presence of postoperative nausea, vomiting, pruritus, urinary retention, respiratory depression
Postoperative 24 hours period
Patient satisfaction
Postoperative 24 hours period
Study Arms (2)
Group QL Block
ACTIVE COMPARATORA convex transducer will be placed in the transverse plane on the flank cranial to the iliac crest to visualise the transverse process of the 4th lumbar vertebra, erector spina, quadratus lumborum and psoas muscles as a 'Shamrock sign'. The needle will inserted in to the fascial plane between the quadratus lumborum and psoas muscles and 30 ml bupivacaine 0.25% will be administered.
Group PENG+LFCN Block
ACTIVE COMPARATORA linear probe will be placed on the anterior inferior iliac crest in the transverse plane while the patient is in the supine position. After rotating 45 degrees, the pubic ramus, femoral artery and psoas muscle will be visualized. Puncture will be performed in a lateromedial direction until the needle tip reached the plane between the iliopsoas tendon and the iliopubic eminence After a negative aspiration test, 25 ml bupivacaine 0.25% will be injected. Then, the lateral femoral cutaneous nerve (LFCN) block was performed using linear US probe (10-18 MHz).The LFCN will be localized, infero-medially to the antero-superior iliac spine, laterally to the sartorius muscle and 5 ml of bupivacaine 0.25% will be carefully injected.
Interventions
Eligibility Criteria
You may qualify if:
- Physical status according to American Society of Anesthesiologists (ASA ) I-III
You may not qualify if:
- Younger than 40 years old and older than 85
- Patients undergoing general anesthesia
- Allergy or intolerance to one of the study medications
- Infection of the skin at the site of the needle puncture,
- Patients who do not accept the procedure
- History of bleeding diathesis
- ASA IV,
- Chronic gabapentin/pregabalin,opioid use
- Hepatic or renal insufficiency
- Previous operation on the same hip
- BMI \>40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alper KILICASLAN
Konya, Turkey (Türkiye)
Related Publications (2)
Hussain N, Brull R, Speer J, Hu LQ, Sawyer T, McCartney CJL, Abdallah FW. Analgesic benefits of the quadratus lumborum block in total hip arthroplasty: a systematic review and meta-analysis. Anaesthesia. 2022 Oct;77(10):1152-1162. doi: 10.1111/anae.15823. Epub 2022 Aug 10.
PMID: 35947882BACKGROUNDGiron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.
PMID: 30063657BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient, and the outcomes assessor who performs postoperative pain evaluation will not know the group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
November 30, 2022
First Posted
December 16, 2022
Study Start
January 1, 2022
Primary Completion
April 10, 2023
Study Completion
April 21, 2023
Last Updated
December 20, 2024
Record last verified: 2023-04